{"id":"665bd1fe-ed5e-5ada-b5fc-c22a37db1b14","stable_key":"27e0c1cf-7726-5164-8b15-27a631584cd0:choline-pcyt1a-expression","predicate":"reduces","statement":"The patient variants markedly reduced PCYT1A expression.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"14fcc833-c04d-58b2-b87e-78bd4c9607fc","mechanism_event_label":"Less of the pathway enzyme was available.","subject":{"id":"ee3d2c71-ec57-56a3-aaf8-f37914d1c18f","slug":"pcyt1a-2014-patient-genotypes","display_name":"Biallelic PCYT1A loss-of-function genotypes in the 2014 patients","entity_type_key":"protein_state"},"object":{"id":"853caf1b-d565-5e86-a2a6-0faba71ad841","slug":"human-pcyt1a-expression","display_name":"Human PCYT1A protein expression","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"14fcc833-c04d-58b2-b87e-78bd4c9607fc","stable_key":"27e0c1cf-7726-5164-8b15-27a631584cd0:choline-pcyt1a-expression-event","event_type":"biochemical_relationship","label":"Less of the pathway enzyme was available.","description":"The patient variants markedly reduced PCYT1A expression.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"9cfd10ff-429d-55c8-b5ec-f4623fc76751","slug":"pcyt1a","display_name":"Human CTP:phosphocholine cytidylyltransferase alpha / PCYT1A","entity_type_key":"protein"},"role":"affected_enzyme","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"ee3d2c71-ec57-56a3-aaf8-f37914d1c18f","slug":"pcyt1a-2014-patient-genotypes","display_name":"Biallelic PCYT1A loss-of-function genotypes in the 2014 patients","entity_type_key":"protein_state"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"853caf1b-d565-5e86-a2a6-0faba71ad841","slug":"human-pcyt1a-expression","display_name":"Human PCYT1A protein expression","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/choline-research/24889630.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"2a370c0cdea7e750360683ff2fe878373965dc5f385e243fe6b0fce1a332ee99\", \"start_char\": 0, \"end_char\": 1005, \"text_sha256\": \"2a370c0cdea7e750360683ff2fe878373965dc5f385e243fe6b0fce1a332ee99\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Two unrelated patients; PCYT1A expression and PC-synthesis experiments","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Biallelic PCYT1A loss-of-function variants","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Rare genetic disease does not establish choline intake as the cause of common fatty liver or diabetes.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Choline research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"choline","display_name":"Choline","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Human","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Less of the pathway enzyme was available.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[choline-p24889630] Mutations disrupting the Kennedy phosphatidylcholine pathway in humans with congenital lipodystrophy and fatty liver disease. (2014). https://pubmed.ncbi.nlm.nih.gov/24889630/ DOI: 10.1073/pnas.1408523111","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Patient-derived material; liver/adipose phenotype","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"6803f7c7-90a8-5f2d-b501-218a822fff67","evidence_kind":"source_excerpt","locator":"Lines 737-748","start_line":737,"end_line":748,"excerpt":"### choline-pcyt1a-expression\nThe patient variants markedly reduced PCYT1A expression.\nCondition category: machinery_impairment\nnutrient_topic: Choline research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: Less of the pathway enzyme was available.\norganism: Human\ntissue_or_cell_type: Patient-derived material; liver/adipose phenotype\nexperimental_model: Two unrelated patients; PCYT1A expression and PC-synthesis experiments\nlimitations: Rare genetic disease does not establish choline intake as the cause of common fatty liver or diabetes.\nexposure: Biallelic PCYT1A loss-of-function variants\nevidence_span: {\"source_cache\": \"artifacts/choline-research/24889630.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"2a370c0cdea7e750360683ff2fe878373965dc5f385e243fe6b0fce1a332ee99\", \"start_char\": 0, \"end_char\": 1005, \"text_sha256\": \"2a370c0cdea7e750360683ff2fe878373965dc5f385e243fe6b0fce1a332ee99\"}\n[choline-p24889630] Mutations disrupting the Kennedy phosphatidylcholine pathway in humans with congenital lipodystrophy and fatty liver disease. (2014). https://pubmed.ncbi.nlm.nih.gov/24889630/ DOI: 10.1073/pnas.1408523111","model_system":"Two unrelated patients; PCYT1A expression and PC-synthesis experiments","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [choline-p24889630] Mutations disrupting the Kennedy phosphatidylcholine pathway in humans with congenital lipodystrophy and fatty liver disease. (2014). https://pubmed.ncbi.nlm.nih.gov/24889630/ DOI: 10.1073/pnas.1408523111","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"0ba2f05e-5cf5-5bd7-ae5d-0ab4945fcb7b","stable_key":"import-27e0c1cf-7726-5164-8b15-27a631584cd0","title":"Choline: metabolism, signaling and nutrient connections (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"c7afe3d579eba0df6d2a4c26699c653462749e03188348f900c07748cc7282a8","revision_id":"0fa7b48f-2a3c-5adc-b13e-48727dd6f815","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}